乳腺癌乳腺癌乳腺癌

Same author

New chemoimmunotherapy: courtesy of a more flexible Food and Drug Administration.

Cancer investigation·1999

Same author

Tamoxifen for the prevention of breast cancer.

The American journal of medicine·1996

Same author

Breast cancer chemotherapy after fifty years: more cures and less mutilation.

The Mount Sinai journal of medicine, New York·1996

Same author

Tamoxifen chemoprevention--are we throwing out the baby with the bathwater?

Cancer investigation·1994

Same author

Chemotherapy for angiosarcoma of the breast: case report of 30-year survival and analysis of the literature.

Cancer investigation·1994

Same author

Has the cure of breast cancer with chemotherapy become a reality?

Cancer investigation·1994

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

相关实验视频

乳腺癌乳腺癌乳腺癌

相关概念视频

New chemoimmunotherapy: courtesy of a more flexible Food and Drug Administration.

Tamoxifen for the prevention of breast cancer.

Breast cancer chemotherapy after fifty years: more cures and less mutilation.

Tamoxifen chemoprevention--are we throwing out the baby with the bathwater?

Chemotherapy for angiosarcoma of the breast: case report of 30-year survival and analysis of the literature.

Has the cure of breast cancer with chemotherapy become a reality?

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

相关实验视频

乳腺癌 乳腺癌 乳腺癌

相关概念视频

相关文章

New chemoimmunotherapy: courtesy of a more flexible Food and Drug Administration.

Tamoxifen for the prevention of breast cancer.

Breast cancer chemotherapy after fifty years: more cures and less mutilation.

Tamoxifen chemoprevention--are we throwing out the baby with the bathwater?

Chemotherapy for angiosarcoma of the breast: case report of 30-year survival and analysis of the literature.

Has the cure of breast cancer with chemotherapy become a reality?

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

乳腺癌乳腺癌乳腺癌